News

Cloud-Based Pharmacovigilance Software Platform Leverages Cognitive Computing and Industry Standard Practices to Transform Case Processing and Risk Management…

CHICAGO, IL.  APRIL 24, 2017 — ArisGlobal, LLC, a global leader in providing cloud-based software solutions for the life sciences,…

This is the last in the ArisGlobal three-part blog series on Regulatory Affairs transformation. Digitization is sweeping the life sciences industry, disrupting traditional working practices and opening doors to better ways of collaborating, tracking and sharing documents and data, and gaining clear oversight into the product supply chain.

The life sciences industry is confronting a wave of transformational change, brought about by multiple factors, including the growth of new clinical trial markets, a rapid rise in drug development innovation, reimbursement challenges, heightened regulatory requirements and a demand for evidence-based medicine, among many others. These drivers and the resultant changes are having a profound effect on regulatory affairs.

Regulatory affairs departments are accustomed – and even open — to change and adapting their technology and processes in response…

If you’re in Regulatory Affairs, you know the IDMP-compliance-truck is headed your way. Which questions though are plaguing your team?…

Every one of us at some point will take a medication and likely suffer some sort of adverse reaction. However,…

What are the Challenges in the Pharma Industry Regarding Data Privacy? Data privacy and data retention seem to become more…

A preview of DIA’s upcoming Regulatory Conference, where ArisGlobal will unveil its revolutionary regulatory information management system software. It’s no secret, the…

CAMBRIDGE, MA. March 16, 2017— Clinical Research IO (CRIO), a Cambridge-based technology company that has developed the first eSource system…